Tyrosinase inhibitory activity (using L-DOPA as substrate), expressed as IC50, for p-substituted 1–3 thiosemicarbazones and anti-melanogenesis activity (on B16 melanoma cells), reported as IC50, expressed as a function of lipophilicity for 4–6 thiosemicarbazones. The gene discussed is TYR; the disease is melanoma.